These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3123116)

  • 1. Combined glyburide and insulin therapy in type II diabetes.
    Reich A; Abraira C; Lawrence AM
    Diabetes Res; 1987 Oct; 6(2):99-104. PubMed ID: 3123116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study].
    Lundershausen R; Orban S; Pissarek D; Panzram G
    Wien Klin Wochenschr; 1987 Sep; 99(17):603-8. PubMed ID: 3118579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.
    Grunberger G
    J Lab Clin Med; 1993 Apr; 121(4):555-61. PubMed ID: 8454937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
    Kyllästinen M; Groop L
    Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
    Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
    Diabetes Care; 2006 Aug; 29(8):1818-25. PubMed ID: 16873786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
    Falko JM; Osei K
    Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
    Welle S; Nair KS; Lockwood D
    J Clin Endocrinol Metab; 1988 Mar; 66(3):593-7. PubMed ID: 3127418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined insulin-sulfonylurea therapy in type II patients.
    Lewitt MS; Yu VK; Rennie GC; Carter JN; Marel GM; Yue DK; Hooper MJ
    Diabetes Care; 1989 Jun; 12(6):379-83. PubMed ID: 2499443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.
    Groop L; Harno K; Tolppanen EM
    Acta Endocrinol (Copenh); 1984 May; 106(1):97-101. PubMed ID: 6428120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New modalities in diabetes treatment.
    Lawrence AM; Abraira C
    Am J Med; 1988 Nov; 85(5A):153-8. PubMed ID: 3143264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type I diabetes with a combination of glyburide and insulin.
    Gums JG; Curry RW; Montes de Oca G; Skluth HA; Reynolds LR
    Ann Pharmacother; 1992 Jun; 26(6):757-62. PubMed ID: 1611155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 17. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.
    Groop L; Harno K; Nikkilä EA; Pelkonen R; Tolppanen EM
    Acta Med Scand; 1985; 217(1):33-9. PubMed ID: 3919531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.
    Casner PR
    Clin Pharmacol Ther; 1988 Nov; 44(5):594-603. PubMed ID: 3141099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of insulin and glyburide versus glyburide or insulin in the chronic control of patients with type-2 diabetes].
    Cortes Aguirre H; Espinosa López FR; Angulo Cervera JA; Díaz Torres J
    Gac Med Mex; 1993; 129(6):383-6. PubMed ID: 7926425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.
    Lardinois CK; Liu GC; Reaven GM
    Arch Intern Med; 1985 Jun; 145(6):1028-32. PubMed ID: 3923961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.